Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

m5C-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Lung Adenocarcinoma
Junfan Pan, Zhidong Huang, Yiquan Xu
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Biological roles of RNA m5C modification and its implications in Cancer immunotherapy
Hang Song, Jianye Zhang, Bin Liu, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 120
Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 117
Genetic and epigenetic defects of the RNA modification machinery in cancer
Ines Oršolić, Arnaud Carrier, Manel Esteller
Trends in Genetics (2022) Vol. 39, Iss. 1, pp. 74-88
Open Access | Times Cited: 72
The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer
Vincenza Ylenia Cusenza, Annalisa Tameni, Antonino Neri, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42
NSUN2 promotes osteosarcoma progression by enhancing the stability of FABP5 mRNA via m5C methylation
Min Yang, Renxiong Wei, Sheng Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 35
Emerging role of RNA modification and long noncoding RNA interaction in cancer
Liqiong Yang, Lu Tang, Qi Min, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 816-830
Open Access | Times Cited: 8
Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma
Hao Yuan, Jinhui Liu, Li Zhao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 50
Vital roles of m5C RNA modification in cancer and immune cell biology
Xinyu Gu, Xiao Ma, Chao Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m5C‐dependent manner
Xuan Du, Cheng Cheng, Yi Yang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 5, pp. 962-976
Closed Access | Times Cited: 7
5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas
Jiheng Zhang, Nan Wang, Jiasheng Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD
Chao Ma, Zhuoyu Gu, Yang Yang
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 4
RNA epigenetics in pulmonary diseases: Insights into methylation modification of lncRNAs in lung cancer
Junjie Jiang, Minghao Duan, Zheng Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116704-116704
Open Access | Times Cited: 4
Integrative analysis of 5-methylcytosine associated signature in papillary thyroid cancer
Ying Ding, Xinying Li, Wenlong Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
5-Methylcytosine RNA modification and its roles in cancer and cancer chemotherapy resistance
Li Fang, Tingting Liu, Yi Dong, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
5-Methylcytosine RNA Methyltransferases-Related Long Non-coding RNA to Develop and Validate Biochemical Recurrence Signature in Prostate Cancer
Ke Wang, Weibo Zhong, Zining Long, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 24
The Role of m5C-Related lncRNAs in Predicting Overall Prognosis and Regulating the Lower Grade Glioma Microenvironment
Hongshu Zhou, Ming Meng, Zeyu Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Deciphering the vital roles and mechanism of m5C modification on RNA in cancers.
Lemei Zheng, Yumei Duan, Mengna Li, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 6125-6146
Closed Access | Times Cited: 7
RNA modifications in long non-coding RNAs and their implications in cancer biology
Jiexin Li, Xiansong Wang, Hongsheng Wang
Bioorganic & Medicinal Chemistry (2024) Vol. 113, pp. 117922-117922
Closed Access | Times Cited: 2
Identification of the Expression Patterns and Potential Prognostic Role of 5-Methylcytosine Regulators in Hepatocellular Carcinoma
Yong Liu, Shunzhen Zheng, Tao Wang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 11
5-Methylcytosine-Related Long Noncoding RNAs Are Potential Biomarkers to Predict Overall Survival and Regulate Tumor-Immune Environment in Patients with Bladder Cancer
Zhuoyuan Li, Siyu Wang, Yuxian Chen, et al.
Disease Markers (2022) Vol. 2022, pp. 1-26
Open Access | Times Cited: 11
M5C-Related lncRNA Predicts Lung Adenocarcinoma and Tumor Microenvironment Remodeling: Computational Biology and Basic Science
Ming Bai, Chen Sun
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 11
RNA Modifications Meet Tumors
Zhiyuan Yang, Siyu Zhang, Tian Xia, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 3223-3243
Open Access | Times Cited: 11
Identification and Validation of a m5C RNA Modification-Related Gene Signature for Predicting Prognosis and Immunotherapeutic Efficiency of Gastric Cancer
Li Song, Shouguo Wang, Qiankun Li, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 5
NOP2/Sun RNA methyltransferase 2 is a potential pan-cancer prognostic biomarker and is related to immunity
Lemei Zheng, Mengna Li, Jianxia Wei, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0292212-e0292212
Open Access | Times Cited: 5
Molecular Characterization Clinical and Immunotherapeutic Characteristics of m5C Regulator NOP2 Across 33 Cancer Types
Taisheng Liu, Jian Zhang, Chunxuan Lin, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top